EUVIMEDEUVIMED entdecken
Fallbericht

Impact of left bundle branch area pacing-optimized cardiac resynchronized therapy for transthyretin cardiac amyloidosis

Koji Sudo iD, Manabu Uematsu iD, Kazuto Nakamura, Kenji Kuroki iD, Akira Sato iD

European Heart Journal - Cardiovascular Imaging · 2024

DOI: 10.1093/ehjci/jead331 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2024. Verfasst von Koji Sudo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, University of Yamanashi, Shimokato 1110, Chuo, Yamanashi 409-3898, Japan. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiac Resynchronization Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An 83-year-old man was referred to our hospital with worsening chronic heart failure (CHF) with bradycardia of atrial fibrillation. QRS duration in a 12-lead electrocardiography (ECG) was 188 ms with right bundle branch block (RBBB) (Panel A). He was diagnosed with transthyretin cardiac amyloidosis (ATTR-CA) by 99mTc-pyrophosphate scintigraphy (Panel B) and skin biopsy from abdominal wall (TTR, Panel C). Optimal medical therapy with tafamidis meglumine was initiated one year previously, but he remained in New York Heart Association (NYHA) Class III. Echocardiography revealed reduced left ventricular ejection fraction (LVEF) of 42% with pericardial effusion (Panel D, see Supplementary data online, Video S1) and apical sparing (Panel E). We performed left bundle branch area pacing (LBBAP)-optimized cardiac resynchronized therapy (LOT-CRT). A fixed-helix lumen-less lead (SelectSecure 3830, Medtronic, Minneapolis, MN) with fixed-curve sheath (C315His delivery sheath, Medtronic) was inserted deeply into the ventricular septum during echocardiography (Panel F, see Supplementary data online, Video S2), and successful LBBAP was performed. A side-helix LV lead (Attain Stability Quad, Medtronic) was inserted into the lateral branch of the coronary sinus as shown on the fluoroscopic image (Panels G and H). ECG revealed an RBBB pattern during LBBAP, QRS duration of 138 ms (Panel I), and stroke volume (SV) of 70 mL on echocardiography. ECG during LOT-CRT revealed narrow QRS duration of 130 ms (Panel J) with SV of 72 mL. LVEF improved to 60% after LOT-CRT (Panel K, see Supplementary data online, Video S3) with brain natriuretic peptide decreasing from 1814 to 998 pg/mL. The NYHA Class dramatically improved from III to II. LOT-CRT can contribute to greater electrical synchrony and powerful treatment of CHF with ATTR-CA complicated by bradyarrhythmia. Supplementary data are available at European Heart Journal - Cardiovascular Imaging online. Data availability: The data underlying this article are available in the article and in its online supplementary material.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialCardiac Resynchronization TherapyHumansMaleBundle of HisCardiomyopathiesElectrocardiographyTreatment OutcomeAged, 80 and over

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, University of Yamanashi, Shimokato 1110, Chuo, Yamanashi 409-3898, Japan.

ORCID-Profile: Koji Sudo, Manabu Uematsu, Kenji Kuroki, Akira Sato

Zitieren

APA

Sudo, K., Uematsu, M., Nakamura, K., Kuroki, K., & Sato, A. (2024). Impact of left bundle branch area pacing-optimized cardiac resynchronized therapy for transthyretin cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jead331

Vancouver

Sudo K, Uematsu M, Nakamura K, Kuroki K, Sato A. Impact of left bundle branch area pacing-optimized cardiac resynchronized therapy for transthyretin cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging. 2024. doi:10.1093/ehjci/jead331

BibTeX
@article{Sudo2024,
  author = {Sudo, Koji and Uematsu, Manabu and Nakamura, Kazuto and Kuroki, Kenji and Sato, Akira},
  title = {Impact of left bundle branch area pacing-optimized cardiac resynchronized therapy for transthyretin cardiac amyloidosis},
  journal = {European Heart Journal - Cardiovascular Imaging},
  year = {2024},
  doi = {10.1093/ehjci/jead331}
}
Kostenlos starten →